|
1
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the Human
Development Index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Mathers C and
Parkin DM: GLOBOCAN2008, cancer incidence and mortality worldwide:
IARC CancerBase no. 10. Int J cancer. 136:E359–E386. 2012.
View Article : Google Scholar
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brawley OW, Glynn TJ, Khuri FR, Wender RC
and Seffrin JR: The first Surgeon General's report on smoking and
health: The 50th anniversary. CA Cancer J Clin. 64:5–8. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prevention NCfCD, Smoking HPOo Health, .
The Health Consequences of Smoking-50 Years of Progress: A Report
of the Surgeon General. Public Health Service. Office of the
Surgeon General. (United States). 2014.
|
|
6
|
Nana-Sinkam SP and Powell CA: Molecular
biology of lung cancer: Diagnosis and management of lung cancer,
3rd edition: American College of Chest Physicians evidence-based
clinical practice guidelines. Chest. 143:e30S–e39S. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Egile C, Rouiller I, Xu XP, Volkmann N, Li
R and Hanein D: Mechanism of filament nucleation and branch
stability revealed by the structure of the Arp2/3 complex at actin
branch junctions. PLoS Biol. 3:e3832005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ridley AJ: Rho-related proteins: Actin
cytoskeleton and cell cycle. Curr Opin Genet Dev. 5:24–30. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schaefer L, Prakash S and Zoghbi HY:
Cloning and characterization of a novelrho-type
GTPase-activating protein gene (ARHGAP6) from the critical
region for microphthalmia with linear skin defects. Genomics.
46:268–277. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tribioli C, Droetto S, Bione S, Cesareni
G, Torrisi MR, Lotti LV, Lanfrancone L, Toniolo D and Pelicci P: An
X chromosome-linked gene encoding a protein with characteristics of
a rhoGAP predominantly expressed in hematopoietic cells. Proc Natl
Acad Sci USA. 93:695–699. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Yang L and Yin Y: Inhibitory effects
of Arhgap6 on cervical carcinoma cells. Tumour Biol. 37:1411–1425.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo F, Liu Y, Huang J, Li Y, Zhou G, Wang
D, Li Y, Wang J and Xie P: Identification of Rho GTPase activating
protein 6 isoform 1 variant as a new molecular marker in human
colorectal tumors. Pathol Oncol Res. 16:319–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Faraji SN, Mojtahedi Z, Ghalamfarsa G and
Takhshid MA: N-myc downstream regulated gene 2 overexpression
reduces matrix metalloproteinase-2 and −9 activities and cell
invasion of A549 lung cancer cell line in vitro. Iran J Basic Med
Sci. 18:773–779. 2015.PubMed/NCBI
|
|
15
|
Xu X, Cao L, Zhang Y, Yin Y, Hu X and Cui
Y: Network analysis of DEGs and verification experiments reveal the
notable roles of PTTG1 and MMP9 in lung cancer. Oncol Lett.
15:257–263. 2018.PubMed/NCBI
|
|
16
|
Wójcik E, Jakubowicz J, Skotnicki P,
Saskorczyńska B and Kulpa JK: IL-6 and VEGF in small cell lung
cancer patients. Anticancer Res. 30:1773–1778. 2010.PubMed/NCBI
|
|
17
|
Cai J, Li R, Xu X, Zhang L, Wu S, Yang T,
Fang L, Wu J, Zhu X, Li M and Huang Y: URGCP promotes non-small
cell lung cancer invasiveness by activating the NF-κB-MMP-9
pathway. Oncotarget. 6:36489–36504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zuo J, Wen M, Li S, Lv X, Wang L, Ai X and
Lei M: Overexpression of CXCR4 promotes invasion and migration of
non-small cell lung cancer via EGFR and MMP-9. Oncol Lett.
14:7513–7521. 2017.PubMed/NCBI
|
|
19
|
Goudar RK and Vlahovic G: Hypoxia,
angiogenesis, and lung cancer. Curr Oncol Rep. 10:277–282. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lucchi M, Mussi A, Fontanini G, Faviana P,
Ribechini A and Angeletti CA: Small cell lung carcinoma (SCLC): The
angiogenic phenomenon. Eur J Cardiothorac Surg. 21:11052002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu H and Jove R: The STATs of cancer-new
molecular targets come of age. Nat Rev Cancer. 4:94–105. 2004.
View Article : Google Scholar
|
|
22
|
Leong H, Mathur PS and Greene GL: Green
tea catechins inhibit angiogenesis through suppression of STAT3
activation. Breast Cancer Res Treat. 117:505–515. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song L, Rawal B, Nemeth JA and Haura EB:
JAK1 activates STAT3 activity in non-small-cell lung cancer cells
and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Mol Cancer Ther. 10:481–494. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yeh HH, Lai WW, Chen HH, Liu HS and Su WC:
Autocrine IL-6-induced Stat3 activation contributes to the
pathogenesis of lung adenocarcinoma and malignant pleural effusion.
Oncogene. 25:4300–4309. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martín F, Santolaria F, Batista N, Milena
A, González-Reimers E, Brito MJ and Oramas J: Cytokine levels (IL-6
and IFN-gamma), acute phase response and nutritional status as
prognostic factors in lung cancer. Cytokine. 11:80–86. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yanagawa H, Sone S, Takahashi Y, Haku T,
Yano S, Shinohara T and Ogura T: Serum levels of interleukin 6 in
patients with lung cancer. Br J Cancer. 71:1095–1098. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hong J, Kang B, Kim A, Hwang S, Ahn J, Lee
S, Kim J, Park JH and Cheon DS: Development of a highly sensitive
real-time one step RT-PCR combined complementary locked primer
technology and conjugated minor groove binder probe. Virol J.
8:3302011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kobayashi T, Hino S, Oue N, Asahara T,
Zollo M, Yasui W and Kikuchi A: Glycogen synthase kinase 3 and
h-prune regulate cell migration by modulating focal adhesions. Mol
Cell Biol. 26:898–911. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng X, Yang Y, Fan Z, Yu L, Bai H, Zhou
B, Wu X, Xu H, Fang M, Shen A, et al: MKL1 potentiates lung cancer
cell migration and invasion by epigenetically activating MMP9
transcription. Oncogene. 34:5570–5581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takeda A, Stoeltzing O, Ahmad SA, Reinmuth
N, Liu W, Parikh A, Fan F, Akagi M and Ellis LM: Role of
angiogenesis in the development and growth of liver metastasis. Ann
Surg Oncol. 9:610–616. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang ZH, Bi-Dan HU, Min YU and Zhang YB:
Expressions of leptin, STAT3, p-STAT3 and bcl-2 in lung cancer and
their clinical significance. Tumor. 30:529–534. 2010.
|
|
33
|
Heinrich PC, Behrmann I, Haan S, Hermanns
HM, Müller-Newen G and Schaper F: Principles of interleukin
(IL)-6-type cytokine signaling and its regulation. Biochem J.
374:1–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schafer ZT and Brugge JS: IL-6 involvement
in epithelial cancers. J Clin Invest. 117:3660–3663. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang T, Nelson RA, Bogardus A and Grannis
FW Jr: Five-year lung cancer survival: Which advanced stage
nonsmall cell lung cancer patients attain long-term survival?
Cancer. 116:1518–1525. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Teng JP, Yang ZY, Zhu YM, Ni D, Zhu ZJ and
Li XQ: The roles of ARHGAP10 in the proliferation, migration and
invasion of lung cancer cells. Oncol Lett. 14:4613–4618. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Tian X, Han R, Zhang X, Wang X,
Shen H, Xue L, Liu Y, Yan X, Shen J, et al: Downregulation of
miR-486-5p contributes to tumor progression and metastasis
by targeting protumorigenic ARHGAP5 in lung cancer.
Oncogene. 33:1181–1189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zuo J, Ishikawa T, Boutros S, Xiao Z,
Humtsoe JO and Kramer RH: Bcl-2 overexpression induces a partial
epithelial to mesenchymal transition and promotes squamous
carcinoma cell invasion and metastasis. Mol Cancer Re. 8:170–182.
2010. View Article : Google Scholar
|
|
39
|
Gao J, Liu X, Yang F, Liu T, Yan Q and
Yang X: By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM
inhibits breast cancer cell growth and metastasis. Oncotarget.
6:27187–27198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shon SK, Kim A, Kim JY, Kim KI, Yang Y and
Lim JS: Bone morphogenetic protein-4 induced by NDRG2 expression
inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res
Commun. 385:198–203. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Elbadrawy MK, Yousef AM, Shaalan D and
Elsamanoudy AZ: Matrix metalloproteinase-9 expression in lung
cancer patients and its relation to serum mmp-9 activity,
pathologic type, and prognosis. J Bronchology Interv Pulmonol.
21:327–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu J, Ping W, Zu Y and Sun W:
Correlations of lysyl oxidase with MMP2/MMP9 expression and its
prognostic value in non-small cell lung cancer. Int J Clin Exp
Pathol. 7:6040–6047. 2014.PubMed/NCBI
|
|
43
|
Matsuyama W, Hashiguchi T, Mizoguchi A,
Iwami F, Kawabata M, Arimura K and Osame M: Serum levels of
vascular endothelial growth factor dependent on the stage
progression of lung cancer. Chest. 118:948–951. 2000. View Article : Google Scholar : PubMed/NCBI
|
